Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Price:
13.9489
USD
-3.33%
Market Closed
Market Cap:
$164.3m
Relative Value
The Relative Value of one
TNXP
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 13.9489 USD,
Tonix Pharmaceuticals Holding Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TNXP Relative Value
HIDDEN
Multiples Across Competitors
TNXP Competitors Multiples
Tonix Pharmaceuticals Holding Corp Competitors
Tonix Pharmaceuticals Holding Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
|
163.2m USD | 16 | -1.7 | 0.3 | 0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
407.6B USD | 6.8 | 173.5 | 16.7 | 23.8 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208.4B USD | 5.7 | 27 | 15.4 | 15.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.3B USD | 6.3 | 21.8 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.9B USD | 10.5 | 31.8 | 24.4 | 25.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.3 | 13.7 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.9B AUD | 3.2 | 16.7 | 11.5 | 14.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.9B EUR | 13.1 | 30.9 | 52.4 | 53.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
